241 related articles for article (PubMed ID: 33012494)
1. [Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Álvarez-Alegret R; Rojo Todo F; Garrido P; Bellosillo B; Rodríguez-Lescure Á; Rodríguez-Peralto JL; Vera R; de Álava E; García-Campelo R; Remon J
Rev Esp Patol; 2020; 53(4):234-245. PubMed ID: 33012494
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Remon J; García-Campelo R; de Álava E; Vera R; Rodríguez-Peralto JL; Rodríguez-Lescure Á; Bellosillo B; Garrido P; Rojo F; Álvarez-Alegret R
Clin Transl Oncol; 2020 Jun; 22(6):823-834. PubMed ID: 31559582
[TBL] [Abstract][Full Text] [Related]
3. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract][Full Text] [Related]
4. [Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
López-Ríos F; Paz-Ares L; Sanz J; Isla D; Pijuan L; Felip E; Gómez-Román JJ; de Castro J; Conde E; Garrido P
Rev Esp Patol; 2020; 53(3):167-181. PubMed ID: 32650968
[TBL] [Abstract][Full Text] [Related]
5. [Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Palacios Calvo J; Albanell J; Rojo F; Ciruelos E; Aranda-López I; Cortés J; García-Caballero T; Martín M; López-García MÁ; Colomer R
Rev Esp Patol; 2018; 51(2):97-109. PubMed ID: 29602380
[TBL] [Abstract][Full Text] [Related]
6. Letter to the Editor regarding "Liquid biopsy in oncology: a consensus statement of the Spanish society of pathology and the Spanish society of medical oncology".
Enko D; Kriegshäuser G
Clin Transl Oncol; 2021 Jul; 23(7):1494-1495. PubMed ID: 33528812
[No Abstract] [Full Text] [Related]
7. Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
García-Alfonso P; Salazar R; García-Foncillas J; Musulén E; García-Carbonero R; Payá A; Pérez-Segura P; Ramón y Cajal S; Navarro S; ;
Clin Transl Oncol; 2012 Oct; 14(10):726-39. PubMed ID: 22855150
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Trigo J; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
Clin Transl Oncol; 2022 Oct; 24(10):1890-1902. PubMed ID: 35739348
[TBL] [Abstract][Full Text] [Related]
9. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
Vera R; Ibarrola-de-Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
Clin Transl Oncol; 2022 Nov; 24(11):2107-2119. PubMed ID: 36008616
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Garrido P; de Castro J; Concha Á; Felip E; Isla D; López-Ríos F; Paz-Ares L; Ramírez J; Sanz J; Gómez JJ
Clin Transl Oncol; 2012 May; 14(5):338-49. PubMed ID: 22551539
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Colomer R; Aranda-López I; Albanell J; García-Caballero T; Ciruelos E; López-García MÁ; Cortés J; Rojo F; Martín M; Palacios-Calvo J
Clin Transl Oncol; 2018 Jul; 20(7):815-826. PubMed ID: 29273958
[TBL] [Abstract][Full Text] [Related]
12. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
Vera R; Ibarrola-de Andrés C; Adeva J; Pérez-Rojas J; García-Alfonso P; Rodríguez-Gil Y; Macarulla T; Serrano-Piñol T; Mondéjar R; Madrigal-Rubiales B
Rev Esp Patol; 2023; 56(1):32-44. PubMed ID: 36599598
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Pérez JMT; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
Rev Esp Patol; 2023; 56(1):45-57. PubMed ID: 36599600
[TBL] [Abstract][Full Text] [Related]
14. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
Lin VTG; Yang ES
J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
[TBL] [Abstract][Full Text] [Related]
15. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
[TBL] [Abstract][Full Text] [Related]
16. [2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary].
Matías-Guiu X; Fusté V; Iglesias L; Balañá C; Concha Á; de la Cruz-Merino L; Nieto B; Pané M; Sanz J; Losa F
Rev Esp Patol; 2019; 52(1):33-44. PubMed ID: 30583830
[TBL] [Abstract][Full Text] [Related]
17. Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.
Quintanar T; Font C; Gallardo E; Barba R; Obispo B; Díaz-Pedroche C
Clin Transl Oncol; 2021 Apr; 23(4):697-708. PubMed ID: 32885400
[TBL] [Abstract][Full Text] [Related]
18. [Multidisciplinary consensus on optimizing the detection of NTRK gene alterations in tumours].
Rojo F; Colomer R; López-Ríos F; Bautista F; Álvarez R; de Álava E; Hladun R; Garrido P
Rev Esp Patol; 2021; 54(4):250-262. PubMed ID: 34544555
[TBL] [Abstract][Full Text] [Related]
19. [Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer].
Garrido P; Aldaz A; Calleja MÁ; de Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
Rev Esp Patol; 2018; 51(3):154-159. PubMed ID: 30012308
[TBL] [Abstract][Full Text] [Related]
20. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
